PIK3CA mutations were present in 18% of our ICC samples, which is slightly lower than previously published data from tissue samples, which have been reported in 22% of tumors from Latin-American and up to 45% in HIV-negative tumors from Uganda4,6,11. Here, PIK3CA is linked to intrahepatic cholangiocarcinoma.